Nov 15, 2024
17:48

Renewal of Existing Continuing Connected Transactions with Tianjin Pharmaceutical Group Co., Ltd.

Continuing Connected Transaction

00882 - TIANJIN DEV

Oct 30, 2024
06:02

Unaudited Financial Results for the nine months ended 30 September 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.

Results of a Subsidiary

00882 - TIANJIN DEV

Sep 26, 2024
20:11

Discloseable Transaction - Subscription of Wealth Management Product

Discloseable Transaction

00882 - TIANJIN DEV

Aug 29, 2024
16:55

Continuing Connected Transactions - Products Procurement Master Agreement and Integrated Services Master Agreement

Continuing Connected Transaction

00882 - TIANJIN DEV

Aug 29, 2024
12:03

Interim Dividend for the six months ended 30 June 2024

Dividend or Distribution (Announcement Form)

00882 - TIANJIN DEV

Aug 29, 2024
12:00

Announcement of Interim Results for the six months ended 30 June 2024

Closure of Books or Change of Book Closure Period

00882 - TIANJIN DEV

Aug 23, 2024
06:08

Unaudited Financial Results for the six months ended 30 June 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.

Results of a Subsidiary

00882 - TIANJIN DEV

Aug 19, 2024
12:01

Date of Board Meeting

Date of Board Meeting

00882 - TIANJIN DEV